Cargando…

Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1

BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited disorder characterized by the simultaneous occurrence of endocrine tumors in target tissues (mainly the pituitary, endocrine pancreas, and parathyroid glands). MEN1 is caused by mutations in the MEN1 gene, which functions as...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong Min, Yu, Seung Hee, Yoon, Hyun Hwa, Lee, Kang Lock, Eom, Young Sil, Lee, Kiyoung, Kim, Byung-Joon, Kim, Yeun Sun, Park, Ie Byung, Kim, Kwang-Won, Lee, Sihoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091494/
https://www.ncbi.nlm.nih.gov/pubmed/25031887
http://dx.doi.org/10.3803/EnM.2014.29.2.146
_version_ 1782480773678366720
author Lee, Dong Min
Yu, Seung Hee
Yoon, Hyun Hwa
Lee, Kang Lock
Eom, Young Sil
Lee, Kiyoung
Kim, Byung-Joon
Kim, Yeun Sun
Park, Ie Byung
Kim, Kwang-Won
Lee, Sihoon
author_facet Lee, Dong Min
Yu, Seung Hee
Yoon, Hyun Hwa
Lee, Kang Lock
Eom, Young Sil
Lee, Kiyoung
Kim, Byung-Joon
Kim, Yeun Sun
Park, Ie Byung
Kim, Kwang-Won
Lee, Sihoon
author_sort Lee, Dong Min
collection PubMed
description BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited disorder characterized by the simultaneous occurrence of endocrine tumors in target tissues (mainly the pituitary, endocrine pancreas, and parathyroid glands). MEN1 is caused by mutations in the MEN1 gene, which functions as a tumor suppressor and consists of one untranslated exon and nine exons encoding the menin protein. This condition is usually suspected when we encounter patients diagnosed with tumors in multiple endocrine organs, as mentioned above. METHODS: A 65-year-old woman who underwent surgery for a pancreatic tumor (serous cystadenoma) 5 years previously was referred to our hospital due to neurologic symptoms of diplopia and left ptosis. Brain magnetic resonance imaging revealed a 3.4-cm lesion originating from the cavernous sinus wall and extending into the sellar region. It was thought to be a nonfunctioning tumor from the results of the combined pituitary function test. Incidentally, we found that she also had a pancreatic tumor, indicating the necessity of genetic analysis for MEN1. RESULTS: Genomic analysis using peripheral leukocytes revealed a heterozygous c.1621G>A mutation in the MEN1 gene that was previously reported to be either a pathogenic mutation or a simple polymorphism. We pursued a stereotactic approach to the pituitary lesion, and microscopic findings of the tumor revealed it to be an intrasellar cavernous hemangioma, a rare finding in the sellar region and even rarer in relation to oculomotor palsy. The patient recovered well from surgery, but refused further evaluation for the pancreatic lesion. CONCLUSION: There is great emphasis placed on genetic testing in the diagnosis of MEN1, but herein we report a case where it did not assist in diagnosis, hence, further discussion on the role of genetic testing in this disease is needed. Also, in cases of pituitary tumor with cranial nerve palsy, despite its low prevalence, intrasellar cavernous hemangioma could be suspected.
format Online
Article
Text
id pubmed-4091494
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-40914942014-07-16 Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1 Lee, Dong Min Yu, Seung Hee Yoon, Hyun Hwa Lee, Kang Lock Eom, Young Sil Lee, Kiyoung Kim, Byung-Joon Kim, Yeun Sun Park, Ie Byung Kim, Kwang-Won Lee, Sihoon Endocrinol Metab (Seoul) Original Article BACKGROUND: Multiple endocrine neoplasia type 1 (MEN1) is a rare inherited disorder characterized by the simultaneous occurrence of endocrine tumors in target tissues (mainly the pituitary, endocrine pancreas, and parathyroid glands). MEN1 is caused by mutations in the MEN1 gene, which functions as a tumor suppressor and consists of one untranslated exon and nine exons encoding the menin protein. This condition is usually suspected when we encounter patients diagnosed with tumors in multiple endocrine organs, as mentioned above. METHODS: A 65-year-old woman who underwent surgery for a pancreatic tumor (serous cystadenoma) 5 years previously was referred to our hospital due to neurologic symptoms of diplopia and left ptosis. Brain magnetic resonance imaging revealed a 3.4-cm lesion originating from the cavernous sinus wall and extending into the sellar region. It was thought to be a nonfunctioning tumor from the results of the combined pituitary function test. Incidentally, we found that she also had a pancreatic tumor, indicating the necessity of genetic analysis for MEN1. RESULTS: Genomic analysis using peripheral leukocytes revealed a heterozygous c.1621G>A mutation in the MEN1 gene that was previously reported to be either a pathogenic mutation or a simple polymorphism. We pursued a stereotactic approach to the pituitary lesion, and microscopic findings of the tumor revealed it to be an intrasellar cavernous hemangioma, a rare finding in the sellar region and even rarer in relation to oculomotor palsy. The patient recovered well from surgery, but refused further evaluation for the pancreatic lesion. CONCLUSION: There is great emphasis placed on genetic testing in the diagnosis of MEN1, but herein we report a case where it did not assist in diagnosis, hence, further discussion on the role of genetic testing in this disease is needed. Also, in cases of pituitary tumor with cranial nerve palsy, despite its low prevalence, intrasellar cavernous hemangioma could be suspected. Korean Endocrine Society 2014-06 2014-06-26 /pmc/articles/PMC4091494/ /pubmed/25031887 http://dx.doi.org/10.3803/EnM.2014.29.2.146 Text en Copyright © 2014 Korean Endocrine Society http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Lee, Dong Min
Yu, Seung Hee
Yoon, Hyun Hwa
Lee, Kang Lock
Eom, Young Sil
Lee, Kiyoung
Kim, Byung-Joon
Kim, Yeun Sun
Park, Ie Byung
Kim, Kwang-Won
Lee, Sihoon
Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title_full Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title_fullStr Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title_full_unstemmed Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title_short Genetic Analysis of Multiple Endocrine Neoplasia Type 1 (MEN1) Leads to Misdiagnosis of an Extremely Rare Presentation of Intrasellar Cavernous Hemangioma as MEN1
title_sort genetic analysis of multiple endocrine neoplasia type 1 (men1) leads to misdiagnosis of an extremely rare presentation of intrasellar cavernous hemangioma as men1
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091494/
https://www.ncbi.nlm.nih.gov/pubmed/25031887
http://dx.doi.org/10.3803/EnM.2014.29.2.146
work_keys_str_mv AT leedongmin geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT yuseunghee geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT yoonhyunhwa geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT leekanglock geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT eomyoungsil geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT leekiyoung geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT kimbyungjoon geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT kimyeunsun geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT parkiebyung geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT kimkwangwon geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1
AT leesihoon geneticanalysisofmultipleendocrineneoplasiatype1men1leadstomisdiagnosisofanextremelyrarepresentationofintrasellarcavernoushemangiomaasmen1